Burrill
& Company's 25th annual report on the biotech industry
Reinventing the Industry
Considered required reading by top executives in the life
science industry, this book is an invaluable, one-stop resource
to make sense of the changing landscape.
In Looking Back to See Ahead, you will discover:
- How pharmaceutical companies are reinventing themselves to
address their pipeline problems and the competition from
generics
- New strategies investors are pursuing to improve their returns
- How the convergence of wireless, mobile, and Internet
technologies is making personalized medicine a reality
- The global interplay between science, business, regulatory,
reimbursement, politics and policy
Comprehensive, unparalleled coverage of key trends makes Looking
Back to See Ahead a critical resource for senior executives, as
well as business development, sales, investment, legal, economic
development, and other professionals who support the industry,
to stay competitive in a fast-moving world.
G. Steven Burrill has been involved in the growth and prosperity
of the biotechnology industry for more than 45 years. In 2002,
Mr. Burrill was recognized as a biotech investment visionary by
Scientific American magazine, and in 2008 he received the BayBio
Pantheon DiNA lifetime achievement award for his worldwide
biotech leadership. He is an advisor to University of Illinois
Institute for Genomic Biology, University of Wisconsin College
of Agricultural and Life Sciences, University of California,
Davis, University of Minnesota College of Biological Sciences,
and the Duke University Institute for Genome Science and Policy,
and is an adjunct professor at University of California, San
Francisco. He is the founder and CEO of Burrill & Company, a
global financial services firm exclusively serving the life
sciences industry.
Click here to
view the table of contents and a list of charts and graphs.
BIOTECH 2011 Order Options:
Digital Copy only:
$225
Print Copy only:
$250
Print and Digital Copy:
$425
